A Johns Hopkins virologist has answers for you about the latest COVID variant.
Vaccines, tests, and antivirals are still effective tools against the most recent COVID surge, says Andy Pekosz, a professor in the molecular microbiology and immunology department at the Johns Hopkins University Bloomberg School of Public Health
In early November 2023, the JN.1 variant caused less than 5% of COVID-19 cases in the US. Now it is estimated to cause more than 60% of them. Virologists, including Pekosz, are paying attention.
Here, he explains what virologists are seeing, what this new variant means for case rates and treatments, and why it’s so important for more people to get the updated COVID-19 vaccine rolled out this fall:
Source: Johns Hopkins University
